Status:
COMPLETED
Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Angioedema
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to describe quality of life in hereditary or acquired non drug-related bradykinin-mediated angioedema patients, using validated questionnaires
Eligibility Criteria
Inclusion
- Clinically documented angioedema due to C1 inhibitor deficiency, hereditary (type I et II) or acquired
- Clinically documented angioedema with normal C1 inhibitor activity (hereditary type III)
Exclusion
- Acquired angioedema with normal C1 inhibitor activity (former "drug-induced")
- Minor subjects
- Vulnerable subjects (under guardianship/curatorship/tutorship)
- Pregnant women
Key Trial Info
Start Date :
July 11 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03240991
Start Date
July 11 2016
End Date
December 1 2016
Last Update
April 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Besançon
Besançon, France, 25000